Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
UM ›
UMIBRI
Trademark search for:
UMIBRI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-12-27 — Application filed
2012-04-06 — Sn assigned for sect 66a appl from ib
2012-04-10 — Application filed
2012-04-11 — Approved for pub - principal register
2012-04-11 — Application filed
2012-04-11 — Assigned to examiner
2012-04-17 — Application filed
2012-04-25 — Notice of publication
2012-05-15 — Published for opposition
2012-07-31 — Registered-principal register
2012-08-30 — Grant of protection created, to be sent to ib
2012-08-30 — Final disposition recorded
2012-08-30 — Final disposition recorded
2012-10-07 — Notification processed by ib
2013-05-31 — Change of name/address rec'd from ib
2013-07-13 — Correction transaction received from ib
2013-07-15 — Correction from the ib examined, no action is needed
2019-03-08 — Cancelled section 71
2019-11-08 — Total invalidation of reg ext protection created
2019-11-30 — Total invalidation of reg ext protection sent to ib
2019-11-30 — Invalidation processed
2020-01-03 — Total invalidation processed by the ib
2020-10-23 — New representative at ib received
2021-12-27 — Final status recorded
2022-07-23 — Death of international registration
2022-07-23 — Notification of effect of cancellation of intl reg mailed
Owner Information
Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP
Astellas Pharma Inc.
JP
Correspondent
HAYATSU Takahisa Kagurazaka Technos 5F, 4 Tsukiji-machi, Tokyo 162-0818,
Filing Details
Filing Date:
2011-12-27
Status Date:
2021-12-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.